Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children

Trial Profile

Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Sedation
  • Focus Pharmacokinetics
  • Acronyms PINDEX
  • Most Recent Events

    • 11 Sep 2017 Planned End Date changed from 1 Dec 2019 to 31 May 2018.
    • 11 Sep 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 09 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top